Tarsus Pharmaceuticals, Inc. (TARS) Cash Flow Statement

Because net loss and operating cash flow frequently move in opposite directions across the ten quarters, the OCF-to-net-income ratio swings between extremes and offers little stable signal. The 2026Q3 net loss of $668.3M paired with operating cash flow of only -$6.0M suggests the headline loss is dominated by non-cash or non-operating items, though the data alone does not reveal their nature and this warrants further investigation. Investors should treat reported earnings quality as unresolved until the drivers of the 2026Q3 charge are identified.

The quarterly FCF series alternates between modest positive and negative readings rather than trending steadily upward, which suggests working capital timing and collection cadence are driving much of the variation. A single strong quarter at a 36.1% FCF margin is insufficient to establish a sustained cash generation base given the surrounding negative quarters. Investors should monitor whether the next several quarters hold positive FCF before extrapolating the 2026Q2 result.

Low capex intensity is consistent with an outsourced-manufacturing commercial model in which the company does not carry heavy plant maintenance obligations. Depreciation and amortization of roughly $0.4M to $1.0M per quarter is small relative to SBC of $6.9M to $27.2M, so non-cash equity compensation is a far larger add-back than asset replacement. This profile means the cash economics depend more on operating spend discipline than on capital allocation choices.

The magnitude of working capital movement relative to operating cash flow indicates that receivables, inventory, or payables timing, rather than core profitability, is governing the quarterly cash profile. Such large swings are typical of a launch-stage product where wholesaler stocking and gross-to-net adjustments can shift cash receipts between periods. Investors should watch whether collections normalize, as persistent working capital drag would indicate that reported revenue is converting to cash more slowly than the top line implies.